This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takeda, Y. Articles by Takeda, R. Search for Related Content PubMed PubMed Citation Articles by Takeda, Y. Articles by Takeda, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB POTASSIUM

(Hypertension. 1995;25:170-173.)
© 1995 American Heart Association, Inc.

Articles

Production of Aldosterone in Isolated Rat Blood Vessels

Yoshiyu Takeda; Isamu Miyamori; Takashi Yoneda; Kazuhiro Iki; Haruhiko Hatakeyama; Ian A. Blair; Feng-Yin Hsieh; Ryoyu Takeda

From the Second Department of Internal Medicine, School of Medicine, Kanazawa (Japan) University (Y.T., I.M., T.Y., K.I., H.H., R.T.), and the Division of Clinical Pharmacology, Mass Spectrometry Resource, School of Medicine, Vanderbilt University, Nashville, Tenn (I.A.B., F.-Y.H.).

Abstract Angiotensin I (Ang I), Ang II, angiotensinogen, and renin are formed locally in the vasculature. We undertook this study to determine whether the rat mesenteric artery produces aldosterone and to investigate the effects of adrenalectomy, an angiotensin-converting enzyme inhibitor, Ang II, or potassium on aldosterone production in vascular tissue. Isolated rat mesenteric arteries were perfused with Krebs-Ringer solution for 4 hours. The perfusate was collected and chromatographed in a reversed-phase high-performance liquid chromatographic (HPLC) system. The fraction corresponding to synthetic aldosterone was collected and analyzed by mass spectrometry. The aldosterone concentration in the perfusate from the adrenalectomized rats and rats treated with an angiotensin-converting enzyme inhibitor was measured using radioimmunoassay after HPLC separation. The mass spectra of synthetic aldosterone and aldosterone isolated from the perfusate of rat mesenteric arteries were identical. Aldosterone production in the mesenteric arteries of adrenalectomized rats was increased and of rats treated with an angiotensin-converting enzyme inhibitor was reduced compared with that of controls. Ang II (1.9x10^-10 mol/L) and potassium (6.0 mmol/L) increased aldosterone production in mesenteric arteries. This study shows that the rat mesenteric artery produces aldosterone and that the intravascular renin-angiotensin-aldosterone system may contribute to vascular tone.

Key Words: aldosterone • mesenteric artery • rats • adrenalectomy • angiotensin I–converting enzyme inhibitors • angiotensin II

This article has been cited by other articles:

				A. J Rickard and M. J Young Corticosteroid receptors, macrophages and cardiovascular disease J. Mol. Endocrinol., June 1, 2009; 42(6): 449 - 459. [Abstract] [Full Text] [PDF]

				J. M. C. Connell, S. M. MacKenzie, E. M. Freel, R. Fraser, and E. Davies A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function Endocr. Rev., April 1, 2008; 29(2): 133 - 154. [Abstract] [Full Text] [PDF]

				C. L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, I. Stefanon, and J. Bauersachs Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction Hypertension, November 1, 2007; 50(5): 919 - 925. [Abstract] [Full Text] [PDF]

				H. Patni, J. T. Mathew, L. Luan, N. Franki, P. N. Chander, and P. C. Singhal Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1065 - F1071. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin Effects of Aldosterone on the Vasculature Hypertension, March 1, 2006; 47(3): 312 - 318. [Full Text] [PDF]

				T. R. Marcy and T. L. Ripley Aldosterone antagonists in the treatment of heart failure Am. J. Health Syst. Pharm., January 1, 2006; 63(1): 49 - 58. [Abstract] [Full Text] [PDF]

				A. Benetos, J. P. Gardner, M. Kimura, C. Labat, R. Nzietchueng, B. Dousset, F. Zannad, P. Lacolley, and A. Aviv Aldosterone and Telomere Length in White Blood Cells J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1593 - 1596. [Abstract] [Full Text] [PDF]

				W. Chai, I. M. Garrelds, R. de Vries, W. W. Batenburg, J. P. van Kats, and A.H. Jan Danser Nongenomic Effects of Aldosterone in the Human Heart: Interaction With Angiotensin II Hypertension, October 1, 2005; 46(4): 701 - 706. [Abstract] [Full Text] [PDF]

				J. M C Connell and E. Davies The new biology of aldosterone J. Endocrinol., July 1, 2005; 186(1): 1 - 20. [Abstract] [Full Text] [PDF]

				I. Z. Jaffe and M. E. Mendelsohn Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells Circ. Res., April 1, 2005; 96(6): 643 - 650. [Abstract] [Full Text] [PDF]

				B. J Barnes and P. A Howard Eplerenone: A Selective Aldosterone Receptor Antagonist for Patients with Heart Failure Ann. Pharmacother., January 1, 2005; 39(1): 68 - 76. [Abstract] [Full Text] [PDF]

				N. Ahmad, D. G. Romero, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez Do Human Vascular Endothelial Cells Produce Aldosterone? Endocrinology, August 1, 2004; 145(8): 3626 - 3629. [Abstract] [Full Text] [PDF]

				H. Oberleithner, T. Ludwig, C. Riethmuller, U. Hillebrand, L. Albermann, C. Schafer, V. Shahin, and H. Schillers Human Endothelium: Target for Aldosterone Hypertension, May 1, 2004; 43(5): 952 - 956. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin The Many Targets of Aldosterone Hypertension, May 1, 2004; 43(5): 938 - 940. [Full Text] [PDF]

				H. Oberleithner Unorthodox Sites and Modes of Aldosterone Action Physiology, April 1, 2004; 19(2): 51 - 54. [Abstract] [Full Text] [PDF]

				F. K Shieh, E. Kotlyar, and F. Sam Aldosterone and cardiovascular remodelling: focus on myocardial failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 3 - 13. [Abstract] [PDF]

				T. H. Hostetter and H. N. Ibrahim Aldosterone in Chronic Kidney and Cardiac Disease J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2395 - 2401. [Abstract] [Full Text] [PDF]

				P. N. Chander, R. Rocha, J. Ranaudo, G. Singh, A. Zuckerman, and C. T. Stier Jr. Aldosterone Plays a Pivotal Role in the Pathogenesis of Thrombotic Microangiopathy in SHRSP J. Am. Soc. Nephrol., August 1, 2003; 14(8): 1990 - 1997. [Abstract] [Full Text] [PDF]

				P. Ye, C. J. Kenyon, S. M. MacKenzie, J. R. Seckl, R. Fraser, J. M. C. Connell, and E. Davies Regulation of Aldosterone Synthase Gene Expression in the Rat Adrenal Gland and Central Nervous System by Sodium and Angiotensin II Endocrinology, August 1, 2003; 144(8): 3321 - 3328. [Abstract] [Full Text] [PDF]

				J. S. Williams and G. H. Williams 50th Anniversary of Aldosterone J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2364 - 2372. [Full Text] [PDF]

				P. C. White Aldosterone: Direct Effects on and Production by the Heart J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2376 - 2383. [Full Text] [PDF]

				N. J. Brown Eplerenone: Cardiovascular Protection Circulation, May 20, 2003; 107(19): 2512 - 2518. [Abstract] [Full Text] [PDF]

				C. Wang, J. Chao, and L. Chao Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1031 - R1036. [Abstract] [Full Text] [PDF]

				K. T. Weber Aldosterone in Congestive Heart Failure N. Engl. J. Med., December 6, 2001; 345(23): 1689 - 1697. [Full Text] [PDF]

				C. E. Gomez-Sanchez and E. P. Gomez-Sanchez Cardiac Steroidogenesis--New Sites of Synthesis, or Much Ado About Nothing? J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5118 - 5120. [Full Text] [PDF]

				M. J. Young, C. D. Clyne, T. J. Cole, and J. W. Funder Cardiac Steroidogenesis in the Normal and Failing Heart J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5121 - 5126. [Abstract] [Full Text] [PDF]

				P. Lacolley, M. E. Safar, B. Lucet, K. Ledudal, C. Labat, and A. Benetos Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats J. Am. Coll. Cardiol., February 1, 2001; 37(2): 662 - 667. [Abstract] [Full Text] [PDF]

				Y. Takeda, T. Yoneda, M. Demura, I. Miyamori, and H. Mabuchi Cardiac Aldosterone Production in Genetically Hypertensive Rats Hypertension, October 1, 2000; 36(4): 495 - 500. [Abstract] [Full Text] [PDF]

				K. M. Kayes-Wandover and P. C. White Steroidogenic Enzyme Gene Expression in the Human Heart J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2519 - 2525. [Abstract] [Full Text]

				K. T. Weber Aldosterone and Spironolactone in Heart Failure N. Engl. J. Med., September 2, 1999; 341(10): 752 - 755. [Full Text]

				Y. Takeda, K. Furukawa, S. Inaba, I. Miyamori, and H. Mabuchi Genetic Analysis of Aldosterone Synthase in Patients with Idiopathic Hyperaldosteronism J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1633 - 1637. [Abstract] [Full Text]

				H. Hatakeyama, S. Inaba, and I. Miyamori 11ß-Hydroxysteroid Dehydrogenase in Cultured Human Vascular Cells : Possible Role in the Development of Hypertension Hypertension, May 1, 1999; 33(5): 1179 - 1184. [Abstract] [Full Text] [PDF]

				M. E Ullian The role of corticosteroids in the regulation of vascular tone Cardiovasc Res, January 1, 1999; 41(1): 55 - 64. [Full Text] [PDF]

				J.-S. Silvestre, V. Robert, C. Heymes, B. Aupetit-Faisant, C. Mouas, J.-M. Moalic, B. Swynghedauw, and C. Delcayre Myocardial Production of Aldosterone and Corticosterone in the Rat. PHYSIOLOGICAL REGULATION J. Biol. Chem., February 27, 1998; 273(9): 4883 - 4891. [Abstract] [Full Text] [PDF]

				Y. Takeda, I. Miyamori, T. Yoneda, K. Furukawa, S. Inaba, R. Takeda, and H. Mabuchi Brain Nitric Oxide Synthase Messenger RNA in Central Mineralocorticoid Hypertension Hypertension, October 1, 1997; 30(4): 953 - 956. [Abstract] [Full Text]

				A. Benetos, P. Lacolley, and M.E. Safar Prevention of Aortic Fibrosis by Spironolactone in Spontaneously Hypertensive Rats Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1152 - 1156. [Abstract] [Full Text]

				Y. Takeda, I. Miyamori, S. Inaba, K. Furukawa, H. Hatakeyama, T. Yoneda, H. Mabuchi, and R. Takeda Vascular Aldosterone in Genetically Hypertensive Rats Hypertension, January 1, 1997; 29(1): 45 - 48. [Abstract] [Full Text]

				M. E. Ullian, D. J. Hazen-Martin, L. G. Walsh, R. K. Davda, and B. M. Egan Carbenoxolone Damages Endothelium and Enhances Vasoconstrictor Action in Aortic Rings Hypertension, June 1, 1996; 27(6): 1346 - 1352. [Abstract] [Full Text]